{"id":559654,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2017-10-19] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-15","captureTimestamp":"2026-02-15T02:29:38.301000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-18.html","snippet":"Notice - Prescription Drug List (PDL): Multiple Additions (PDF Version - 305 K) October 19, 2017 Our file number: 17-110956-588 The purpose of this Notice of Amendment is to notify about the additions of Defibrotide sodium, Glecaprevir/Pibrentasvir, Midostaurin, Ocrelizumab and…","rawSnapshotUrl":"/api/snapshots/raw/559654","browseUrl":"https://replay.healtharchive.ca/job-6/20260215022938/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-18.html#ha_snapshot=559654","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}